More Post from the Author
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment